Why Comprehensive Testing Matters - Ken Schlosser’s Lung Cancer Story

Labcorp, Rebecca Previs, Ken Schlosser, biomarker, lung cancer, ALK+, advocacy, precision

Biomarker testing helped Ken Schlosser live with stage IV lung cancer for over 6 years. Here's how it shaped his care plan from the start.

Jul 31^st • 23 mins listen